Inspire Medical price target lowered to $190 from $200 at Stifel
Stifel lowered the firm’s price target on Inspire Medical (INSP) to $190 from $200 and keeps a Hold rating on the shares. The firm notes in ...
Inspire Medical Systems: Hold Rating Amidst Limited Revenue Upside and Slow Inspire V Launch
Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...
Piper Sandler maintains overweight on Inspire Medical stock
Piper Sandler reaffirmed its positive stance on Inspire Medical Systems (NYSE:NYSE:INSP), maintaining an Overweight rating with a $260.00 price target. The endorsement comes after a steep 14.15% ...
Hosted on MSN6d
Inspire Medical Stock Falls Despite Solid Preliminary Q4 Revenues
Inspire Medical Systems, Inc. INSP announced preliminary revenues for the fourth quarter and full year 2024 yesterday.